Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan · Delayed Price · Currency is TWD

30.80

+0.20 (0.65%)

Apr 20, 2026, 1:24 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Health Food Products Department			492.78M	494.24M	327.79M	196.47M	139.22M
Health Food Products Department Growth			-0.30%	50.78%	66.84%	41.12%	-
Western Medicine Section			260.55M	218.29M	113.29M	99.33M	110.39M
Western Medicine Section Growth			19.36%	92.68%	14.06%	-10.02%	-
Joint			1.16M	221.00K	-	-	-
Joint Growth			423.53%	-	-	-	-
Total			754.48M	712.75M	441.08M	295.79M	249.61M
Total Growth			5.86%	61.59%	49.12%	18.50%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taiwan			619.47M	594.93M	391.53M	250.19M	198.01M
Taiwan Growth			4.13%	51.95%	56.49%	26.35%	-
Japan			95.62M	70.74M	35.20M	39.75M	49.46M
Japan Growth			35.16%	100.97%	-11.45%	-19.63%	-
Other Countries			33.75M	3.88M	1.92M	5.85M	2.14M
Other Countries Growth			768.98%	101.98%	-67.13%	173.80%	-
Singapore			4.49M	-	-	-	-
South Korea			-	42.97M	12.42M	-	-
South Korea Growth			-	245.95%	-	-	-
Total			753.33M	712.53M	441.08M	295.79M	249.61M
Total Growth			5.73%	61.54%	49.12%	18.50%	-

Source: S&P Global Market Intelligence.